Sec Form 4 Filing - Invesco Ltd. @ Evofem Biosciences, Inc. - 2019-04-10

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Invesco Ltd. 2. Issuer Name and Ticker or Trading Symbol Evofem Biosciences, Inc. [ EVFM] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 1555 PEACHTREE STREET NE, SUITE 1800 3. Date of Earliest Transaction (MM/DD/YY) 04/10/2019 (Street) ATLANTA, GA30309 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Right to Purchase $ 4.5 04/10/2019 J( 1 ) 2,222,222 04/11/2019 06/10/2019 Common Stock 2,222,222 $ 0.0001 2,777,778 ( 2 ) I See Footnote ( 3 ) Right to Purchase $ 6.38 04/10/2019 J( 1 ) 555,556 ( 4 ) ( 5 ) Common Stock 555,556 $ 0.0001 2,777,778 ( 2 ) I See Footnote ( 3 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Invesco Ltd. 1555 PEACHTREE STREET NE SUITE 1800 ATLANTA, GA30309 X Signatures Nancy Tomassone, Global Assurance Officer 04/15/2019 Signature of Reporting Person Date

Explanation of Responses:

( 1 )On April 10, 2019, Invesco Ltd. entered into a Securities Purchase Agreement with the Issuer (the "Securities Purchase Agreement"), pursuant to which Invesco Ltd. has the right, until June 10, 2019, to purchase 2,222,222 shares of common stock at a purchase price of $4.50 per share and warrants to purchase an additional 555,556 shares of common stock at an exercise price equal to $6.38 per share. ( 2 )This number does not include the 212,765 warrants owned by Invesco Ltd. as of the date of this Form 4. Pursuant to the Securities Purchase Agreement, upon and subject to the second closing contemplated therein, Invesco Ltd. will surrender for cancellation warrants to purchase 212,765 shares of common stock existing and outstanding as of the date of the Securities Purchase Agreement. ( 3 )Invesco Ltd. is the beneficial owner of 11,812,910 shares of common stock and warrants to purchase 212,765 common shares acquired by its affiliates, Invesco High Income Fund and Invesco Income Fund. ( 4 )The warrants are exercisable six (6) months following the original issue date ( 5 )The warrants expire seven (7) years following the original issue date.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.